Daratumumab (JNJ-54767414)
Showing 601 - 625 of 632
ADHD Trial in United States (Atomoxetine 80 mg/d, Placebo, OROS methylphenidate HCl 54 mg/d)
Completed
- Attention Deficit Hyperactivity Disorder
- Atomoxetine 80 mg/d
- +5 more
-
Little Rock, Arkansas
- +34 more
Feb 27, 2013
Diabetes, Type 2 Trial in Fort Myers, Miramar (Canagliflozin 50 mg, Canagliflozin 100 mg, Canagliflozin 300 mg)
Completed
- Diabetes Mellitus, Type 2
- Canagliflozin 50 mg
- +3 more
-
Fort Myers, Florida
- +1 more
May 27, 2013
Healthy Trial in Beijing (Treatment A: Canagliflozin 100 mg, Treatment B: Canagliflozin 300 mg, Treatment C: Placebo)
Completed
- Healthy
- Treatment A: Canagliflozin 100 mg
- +2 more
-
Beijing, China(unnamed)
Feb 18, 2013
Diabetes, Type 2 Trial in United States (Placebo, Canagliflozin 300mg/Placebo, Canagliflozin 300mg/Canagliflozin 150mg)
Completed
- Diabetes Mellitus, Type 2
- Placebo
- +3 more
-
Chula Vista, California
- +4 more
Apr 19, 2013
Healthy Trial in Antwerpen (Canagliflozin (JNJ-28431754), Cyclosporine)
Completed
- Healthy
- Canagliflozin (JNJ-28431754)
- Cyclosporine
-
Antwerpen, Belgium(unnamed)
Nov 22, 2012
Healthy Trial (Digoxin 0.5 mg, Digoxin 0.25 mg, Canagliflozin (JNJ-28431754))
Completed
- Healthy
- Digoxin 0.5 mg
- +2 more
- (no location specified)
Nov 16, 2012
Healthy Volunteers Trial in Fukukoka, Hakata (JNJ 10229570-AAA 1.2% cream, JNJ 10229570-AAA 2.4% cream, JNJ 10229570-AAA 3.6%
Completed
- Healthy Volunteers
- JNJ 10229570-AAA 1.2% cream
- +4 more
-
Fukukoka, Japan
- +1 more
Oct 30, 2012
Healthy Trial (Oral contraceptive, Canagliflozin (JNJ-28431754))
Completed
- Healthy
- Oral contraceptive
- Canagliflozin (JNJ-28431754)
- (no location specified)
Nov 16, 2012
Osteoarthritis, Knee Trial in George (Placebo, JNJ-39439335, Naproxen)
Completed
- Osteoarthritis, Knee
- Placebo
- +2 more
-
George, South Africa(unnamed)
Aug 8, 2012
Advanced or Refractory Leukemia, MDS Trial in Baltimore, Houston (JNJ-26481585)
Terminated
- Advanced or Refractory Leukemia
- Myelodysplastic Syndromes
-
Baltimore, Maryland
- +1 more
Sep 13, 2012
Asthma Trial (Placebo, JNJ-39758979 30 mg/d, JNJ-39758979 100 mg/d)
Withdrawn
- Asthma
- Placebo
- +3 more
- (no location specified)
May 10, 2012
Complicated Skin and Skin Structure Infections Trial in United States (JNJ-32729463, linezolid, JNJ-32729463 )
Completed
- Complicated Skin and Skin Structure Infections
- JNJ-32729463
- +3 more
-
Anaheim, California
- +26 more
Dec 9, 2011
Community-Acquired Bacterial Pneumonia (CABP) Trial in Worldwide (JNJ-32729463, moxifloxacin, JNJ-32729463 (Open-Label))
Terminated
- Community-Acquired Bacterial Pneumonia (CABP)
- JNJ-32729463
- +2 more
-
Mobile, Alabama
- +33 more
Dec 5, 2011
Healthy Trial ([11C] JNJ-42491293, [11C] JNJ-42491293 + JNJ-40411813)
Completed
- Healthy
- [11C] JNJ-42491293
- [11C] JNJ-42491293 + JNJ-40411813
- (no location specified)
Jul 21, 2011
Osteoarthritis, Knee Trial (JNJ-39439335; Placebo; Naproxen)
Completed
- Osteoarthritis, Knee
- JNJ-39439335; Placebo; Naproxen
- (no location specified)
Jul 29, 2010
Pain Trial (JNJ-39439335, Placebo)
Completed
- Pain
- JNJ-39439335, Placebo
- (no location specified)
Jul 1, 2010
Healthy, Pharmacokinetics, Drug Interactions Trial (JNJ-31001074; ketoconazole)
Completed
- Healthy
- +2 more
- JNJ-31001074; ketoconazole
- (no location specified)
Apr 29, 2010